Compare Globus Medical Inc. Class A Common Stock (GMED) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globus Medical Inc. Class A Common Stock vs United States Natural Gas Fund — how do they compare? Globus Medical Inc. Class A Common Stock trades at $76.99 (market cap $10.25B), while United States Natural Gas Fund trades at $11.23 (market cap $503.45M). The key difference: Globus Medical Inc. Class A Common Stock is far larger — about 20.4× United States Natural Gas Fund's market cap, and Globus Medical Inc. Class A Common Stock is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globus Medical Inc. Class A Common Stock for 0 Days and United States Natural Gas Fund for 23 Days on average.
| GMED | UNG | |
|---|---|---|
Market Cap | $10.25B | $503.45M |
Volume | 1,059,528 | 39,591,120 |
Sector | Health | Commodities - Energy |
52-Week High | $96.82 | $16.90 |
52-Week Low | $58.33 | $9.63 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $9.76B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.
GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.
UNG trades at $11.41, up 4.49% today, with a bullish technical signal from moving averages. The company reported $65.15M net income for 2024 despite zero revenue, with strong cash holdings of $593.54M and minimal debt. Recent news highlights natural gas market volatility amid Middle East tensions and record U.S. production.
Outlook is mixed: technical momentum supports near-term gains, but zero revenue and negative cash flow (-$251.70M) raise sustainability concerns. Investment opportunity lies in natural gas market exposure, countered by operational risks and dependence on external factors. Monitor earnings quality and cash flow trends closely.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Globus Medical Inc. Class A Common Stock
Globus Medical, Inc. develops and manufactures medical devices for treating musculoskeletal disorders, including spine, orthopedic trauma, and neurosurgical products. It operates in US and internationally, serving surgeons and healthcare providers.
Read more on GMED →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
